EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management Strategies for Helicobacter pylori —Application of the Stewardship Principles

Francis Megraud iD, Emilie Bessède, Tamara Matysiak-Budnik

Helicobacter · 2026-09 · 31 (5)

DOI: 10.1111/hel.70158 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Helicobacter, online erschienen am 13.10.2026. Verfasst von Francis Megraud und 2 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1312 BRIC Team 4, University of Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Helicobacter Infections, Anti-Bacterial Agents, Helicobacter pylori, Antimicrobial Stewardship. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management strategies for Helicobacter pylori treatment are still diverse, especially because of the unequal availability of the drugs needed. In addition, the development of resistance to some antibiotics leads to unsatisfactory results. The role of H. pylori in gastric cancer, which allows the possibility of prevention in the general population by eradicating the bacteria, is a stimulus to have well‐established regimens. This article presents the antimicrobial stewardship principles that can guarantee appropriate treatment. The optimization of the clarithromycin‐based triple therapy includes antimicrobial susceptibility testing for clarithromycin, a higher dose of amoxicillin than in the original regimen, more than twice a day, and a proton pump inhibitor (PPI) like rabeprazole or esomeprazole, all administered for 2 weeks. The other regimen often used, the bismuth quadruple therapy, is optimal with the 3‐in‐1 capsule and a standard or high dose of PPI. In all cases, an eradication control must be performed after 4 to 6 weeks. The so‐called concomitant treatment does not meet stewardship principles. The availability of Potassium‐Competitive Acid Blockers (P‐CABs) in some countries could allow the use of a dual therapy with only amoxicillin, but it must be confirmed by proper trials in Western countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsAnti-Bacterial AgentsHelicobacter pyloriAntimicrobial StewardshipHumansProton Pump InhibitorsDrug Therapy, Combination

Stichwörter der Autor:innen

amoxicillinantimicrobial susceptibility testingbismuth quadruple therapyclarithromycinproton pump inhibitortriple therapy

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • INSERM U1312 BRIC Team 4, University of Bordeaux, Bordeaux, France.
  • IMAD, Hepato-Gastroenterology & Digestive Oncology, University Hospital, Nantes, France.

ORCID-Profile: Francis Megraud

Zitieren

APA

Megraud, F., Bessède, E., & Matysiak-Budnik, T. (2026). Management Strategies for Helicobacter pylori —Application of the Stewardship Principles. Helicobacter, 31(5). https://doi.org/10.1111/hel.70158

Vancouver

Megraud F, Bessède E, Matysiak-Budnik T. Management Strategies for Helicobacter pylori —Application of the Stewardship Principles. Helicobacter. 2026;31(5). doi:10.1111/hel.70158

BibTeX
@article{Megraud2026,
  author = {Megraud, Francis and Bessède, Emilie and Matysiak-Budnik, Tamara},
  title = {Management Strategies for Helicobacter pylori —Application of the Stewardship Principles},
  journal = {Helicobacter},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1111/hel.70158}
}
Kostenlos starten →